Fidelity Investments
CELZ icon

Fidelity Investments’s Creative Medical Technology CELZ Stock Holding History

Fidelity Investments’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-250
Closed -$515 – 5589
2026
Q1 		$515 Buy
+250
New +$489 ﹤0.01% 5161
2025
Q4 		– Sell
-200
Closed -$658 – 5450
2025
Q3 		$658 Buy
+200
New +$620 ﹤0.01% 5066
2023
Q2 		– Sell
-92
Closed -$458 – 5394
2023
Q1 		$458 Buy
+92
New +$522 ﹤0.01% 4809
2022
Q4 		– Sell
-517
Closed -$2K – 5368
2022
Q3 		$2K Buy
+517
New +$3.51K ﹤0.01% 4527

Other funds holding CELZ

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments's CELZ Position: Q2 2026 in Review

Fidelity Investments sold out of Creative Medical Technology (CELZ) in Q2 2026, closing a stake of 250 shares — an estimated $515 sold.

Fidelity Investments first reported a position in CELZ in Q3 2022 and held it in 4 quarters. The position peaked at $2K in Q3 2022. 15 funds tracked by Wall St. Rank hold CELZ as of Q2 2026.

  • Fidelity Investments reported no remaining Creative Medical Technology position as of Q2 2026 after selling out during the quarter.
  • Fidelity Investments sold 250 Creative Medical Technology shares in Q2 2026, an estimated $515.
  • Fidelity Investments first reported a position in Creative Medical Technology in Q3 2022 and held it in 4 quarters.
  • Fidelity Investments's Creative Medical Technology position peaked at $2K in Q3 2022.
  • 15 funds tracked by Wall St. Rank held Creative Medical Technology as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.